CO141 Assessing the Impact of Additional Follow-up Data on Disease-Free Survival (DFS) Projections of Nivolumab and Surveillance in High-Risk, Muscle-Invasive Urothelial Carcinoma (MIUC) Patients Within the CheckMate-274 Trial
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.213
https://www.valueinhealthjournal.com/article/S1098-3015(23)03343-0/fulltext
Title :
CO141 Assessing the Impact of Additional Follow-up Data on Disease-Free Survival (DFS) Projections of Nivolumab and Surveillance in High-Risk, Muscle-Invasive Urothelial Carcinoma (MIUC) Patients Within the CheckMate-274 Trial
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03343-0&doi=10.1016/j.jval.2023.09.213
First page :
Section Title :
Open access? :
No
Section Order :
11543